CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.24% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
5.855
0.85%
Market Trading Hours* (UTC) Open now
Closes on Thursday at 15:30

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
Trading сonditions
Spread 0.035
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.01796 %
Charges from full value of position ($-3.41)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.01796%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.004262 %
Charges from full value of position ($-0.81)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.004262%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5.00%
Stock exchange Germany
Commission on trade 0%

Key Stats
Prev. Close 5.905
Open 5.77
1-Year Change -58.87%
Day's Range 5.76 - 6.045
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 2, 2025 5.905 -0.080 -1.34% 5.985 5.985 5.725
Apr 1, 2025 6.120 0.050 0.82% 6.070 6.185 5.990
Mar 31, 2025 6.040 0.135 2.29% 5.905 6.070 5.740
Mar 28, 2025 6.000 -0.015 -0.25% 6.015 6.040 5.895
Mar 27, 2025 6.075 -0.095 -1.54% 6.170 6.200 5.970
Mar 26, 2025 6.290 -0.130 -2.02% 6.420 6.480 6.265
Mar 25, 2025 6.415 -0.195 -2.95% 6.610 6.665 6.365
Mar 24, 2025 6.585 0.220 3.46% 6.365 6.665 6.330
Mar 21, 2025 6.320 -0.070 -1.10% 6.390 6.435 6.150
Mar 20, 2025 6.415 -0.085 -1.31% 6.500 6.605 6.300
Mar 19, 2025 6.505 -0.090 -1.36% 6.595 6.635 6.405
Mar 18, 2025 6.600 0.070 1.07% 6.530 6.745 6.495
Mar 17, 2025 6.430 0.145 2.31% 6.285 6.495 6.275
Mar 14, 2025 6.300 0.100 1.61% 6.200 6.385 6.125
Mar 13, 2025 6.230 0.110 1.80% 6.120 6.250 6.020
Mar 12, 2025 6.160 -0.070 -1.12% 6.230 6.270 6.065
Mar 11, 2025 6.185 -0.195 -3.06% 6.380 6.500 6.125
Mar 10, 2025 6.355 -0.235 -3.57% 6.590 6.710 6.275
Mar 7, 2025 6.620 -0.090 -1.34% 6.710 6.955 6.540
Mar 6, 2025 6.755 -0.415 -5.79% 7.170 7.250 6.715

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Evotec Company profile

About Evotec SE

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Evotec SE revenues increased 20% to EUR431M. Net income increased from EUR5.8M to EUR247M. Revenues reflect EVT Execute segment increase of 22% to EUR329M, EVT Innovate segment increase of 36% to EUR101.9M, United States segment increase of 32% to EUR142.9M, Others segment increase of 30% to EUR47.5M, United Kingdom segment increase of 8% to EUR47.2M.

Industry: Biotechnology & Medical Research (NEC)

Essener Bogen 7
HAMBURG
HAMBURG 22419
DE

People also watch

BTC/USD

81,382.95 Price
-4.530% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 50.00

US100

18,592.40 Price
-1.450% 1D Chg, %
Long position overnight fee -0.0236%
Short position overnight fee 0.0014%
Overnight fee time 21:00 (UTC)
Spread 1.8

ETH/USD

1,755.85 Price
-6.100% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 1.75

Gold

3,133.98 Price
-0.300% 1D Chg, %
Long position overnight fee -0.0162%
Short position overnight fee 0.0080%
Overnight fee time 21:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 710,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading